Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 2
2018 2
2019 3
2020 5
2021 2
2022 3
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence, treatment and correlates of depression in multiple sclerosis.
Young CA, Langdon D, Rog D, Chhetri SK, Tanasescu R, Kalra S, Webster G, Nicholas R, Ford HL, Woolmore J, Paling D, Tennant A, Mills R; TONiC study group. Young CA, et al. Mult Scler Relat Disord. 2024 Jul;87:105648. doi: 10.1016/j.msard.2024.105648. Epub 2024 Apr 26. Mult Scler Relat Disord. 2024. PMID: 38713965 Free article.
Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.
Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, Talbot K, Harrower T, Faull C, Malaspina A, Annadale J, Mills RJ, Tennant A; Tonic Study Group. Young CA, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):82-90. doi: 10.1080/21678421.2022.2096410. Epub 2022 Sep 6. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 36066075
Rasch analysis of SF-Qualiveen in multiple sclerosis.
Milinis K, Tennant A, A Young C; TONiC Study Group. Milinis K, et al. Neurourol Urodyn. 2017 Apr;36(4):1161-1166. doi: 10.1002/nau.23081. Epub 2016 Jul 26. Neurourol Urodyn. 2017. PMID: 27460549
Assessing disability progression using the WHODAS 2.0 in multiple sclerosis: Investigating clinical and socio-demographic factors in a large longitudinal cohort study (TONiC-MS).
Parker RMA, Tilling K, Mills R, Tennant A, Ben-Shlomo Y, Constantinescu CS, Kalra S, Young CA; TONiC Study Group. Parker RMA, et al. Mult Scler Relat Disord. 2024 Dec 10;93:106228. doi: 10.1016/j.msard.2024.106228. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39706109 Free article.
Development and validation of Spasticity Index-Amyotrophic Lateral Sclerosis.
Milinis K, Tennant A, Mills RJ, Al-Chalabi A, Burke G, Dick DJ, Ealing J, Hanemann CO, Harrower T, McDermott CJ, Majeed T, Pinto A, Talbot K, Williams T, Young CA; TONiC study group. Milinis K, et al. Acta Neurol Scand. 2018 Jul;138(1):47-54. doi: 10.1111/ane.12910. Epub 2018 Feb 21. Acta Neurol Scand. 2018. PMID: 29468643
Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12.
Young CA, Ealing J, McDermott CJ, Williams TL, Al-Chalabi A, Majeed T, Talbot K, Harrower T, Faull C, Malaspina A, Annadale J, Mills RJ, Tennant A; TONiC Study Group. Young CA, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):63-70. doi: 10.1080/21678421.2022.2102926. Epub 2022 Jul 23. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35876069
16 results